| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 10.677 | 21.532 | 21.294 | 30.260 | 28.587 | 37.063 | 41.176 |
| Total Income - EUR | - | - | 0 | 10.677 | 21.532 | 21.294 | 30.260 | 28.587 | 37.063 | 41.176 |
| Total Expenses - EUR | - | - | 32 | 6.507 | 16.819 | 12.249 | 14.485 | 16.056 | 22.321 | 32.350 |
| Gross Profit/Loss - EUR | - | - | -32 | 4.170 | 4.713 | 9.045 | 15.775 | 12.531 | 14.742 | 8.825 |
| Net Profit/Loss - EUR | - | - | -32 | 4.063 | 4.498 | 8.832 | 15.652 | 12.250 | 14.376 | 7.676 |
| Employees | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Neurohemera Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 177 | 1.252 | 2.769 | 2.353 | 3.549 | 2.287 | 7.679 | 78.546 |
| Current Assets | - | - | 231 | 6.836 | 2.342 | 7.101 | 12.746 | 10.695 | 7.741 | 3.155 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 311 | 0 | 0 | 0 | 34 | 0 | 40 |
| Cash | - | - | 231 | 6.525 | 2.342 | 7.101 | 12.746 | 10.661 | 7.741 | 3.115 |
| Shareholders Funds | - | - | 12 | 4.075 | 4.548 | 8.882 | 15.700 | 12.299 | 14.425 | 7.724 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 396 | 4.013 | 564 | 573 | 594 | 683 | 995 | 73.977 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurohemera Srl